Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “NSCLC Patient Characteristics”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Looking for participantsNCT07630961
What this trial is testing

Phase I Study of JFI447 [68Ga]Ga-DFC413 and Comparison to FFG233 [68Ga]Ga-NNS309 in Patients With Solid Tumors

Who this might be right for
Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)Non-small Cell Lung Cancer (NSCLC)HR+/HER2- Ductal Breast Cancer (BC)+4 more
Novartis Pharmaceuticals 66
Not applicableNot Yet RecruitingNCT06768853
What this trial is testing

The Accuracy of Targeted Lymph Node Dissection of Non-small Cell Lung Cancer Patients According to Predictive Models

Who this might be right for
Non-small Cell Lung Cancer
Zhongnan Hospital 60
Early research (Phase 1)Looking for participantsNCT07056556
What this trial is testing

BL-M09D1 in Patients With Locally Advanced or Metastatic Non-Small Cell Lung Cancer and Other Solid Tumors

Who this might be right for
Non-small Cell Lung CancerSolid Tumor
Sichuan Baili Pharmaceutical Co., Ltd. 31
Not applicableStudy completedNCT02727335
What this trial is testing

Description of Clinical Anatomical Features and Long Term Follow-up for Patients With ALK Rearrangements

Who this might be right for
Non-small Cell Lung CancerAnaplastic Lymphoma Kinase Gene Mutation
Intergroupe Francophone de Cancerologie Thoracique 318
Early research (Phase 1)Not Yet RecruitingNCT06602661
What this trial is testing

Reinforced and Non-Reinforced Staple Lines in Fissureless Lobectomy

Who this might be right for
LungLung AdenocarcinomaLung Adenosquamous Carcinoma+6 more
Surrey Thoracic Surgery Group 65
Not applicableStudy completedNCT07532447
What this trial is testing

Metabolomic Characteristics of Patients With Non-small Cell Lung Cancer in Plasma, Tissue and Exhaled Breath Condensate

Who this might be right for
Lung Cancer
People's Hospital of Xinjiang Uygur Autonomous Region 74
Not applicableStudy completedNCT03718117
What this trial is testing

Descriptive Observational Study ALK-2016-CPHG

Who this might be right for
NSCLCCrizotinibALK Gene Rearrangement or ROS1 Gene Rearrangement
Pfizer 73
Not applicableStudy completedNCT07215026
What this trial is testing

Understanding Non-small Cell Lung Cancer Patient Characteristics, Treatment Patterns and Outcomes

Who this might be right for
Non-small Cell Lung Cancer
AstraZeneca 833
Testing effectiveness (Phase 2)Looking for participantsNCT04930432
What this trial is testing

Study of MCLA-129, a Human Bispecific EGFR and cMet Antibody, in Patients With Advanced NSCLC and Other Solid Tumors

Who this might be right for
Solid TumorNon-Small Cell Lung CancerHead and Neck Cancer+1 more
Betta Pharmaceuticals Co., Ltd. 400
Not applicableActive Not RecruitingNCT06269133
What this trial is testing

Evaluation of Cemiplimab in Combination With Platinum-Doublet Chemotherapy in First-Line (1L) Treatment of Advanced Non-Small Cell Lung Cancer (NSCLC) in Adult United States (US) Participants

Who this might be right for
Advanced Non-small Cell Lung Cancer
Regeneron Pharmaceuticals 1,000
Not applicableNot Yet RecruitingNCT06496009
What this trial is testing

The Clinical Characteristics and Efficacy of Immunotherapy in First-line PD-L1-negative Advanced NSCLC Patients

Who this might be right for
NSCLC
Shanghai Pulmonary Hospital, Shanghai, China 845
Not applicableUnknownNCT01330862
What this trial is testing

Epidemiological Study to Describe Non-small-cell Lung Carcinoma (NSCLC) Clinical Management Patterns in MENA. Lung-EPICLIN/ KSA

Who this might be right for
NSCLC Patient Characteristics
AstraZeneca 54
Not applicableStudy completedNCT03959137
What this trial is testing

BEPACT- Lung: Impact of Patient Characteristics on Pneumo-oncologists Non Small Cell Lung Cancer (NSCLC) Systemic Treatment Decision in Belgium

Who this might be right for
Stage IV Non-small Cell Lung Cancer
MSD Belgium BVBA 215
Not applicableStudy completedNCT01522833
What this trial is testing

Non Small Cell Lung Cancer Patients Treated With Erlotinib Six Months or Longer

Who this might be right for
Non Small Cell Lung Cancer
SCRI Development Innovations, LLC 27
Early research (Phase 1)Looking for participantsNCT07801508
What this trial is testing

[68Ga]Ga-DWJ155 in Adult Patients With Solid Tumors

Who this might be right for
Advanced Gastroesophageal AdenocarcinomaAdvanced Breast CancerTriple-negative Breast Cancer+1 more
Novartis Pharmaceuticals 66
Not applicableUnknownNCT04137718
What this trial is testing

Multicenter Observational Study of Chinese Non-Small Cell Lung Cancer (NSCLC) Patients With Rare Driver Gene Mutation

Who this might be right for
ChineseNon-Small Cell Lung Cancer
Shanghai Pulmonary Hospital, Shanghai, China 50,000
Not applicableStudy completedNCT02785562
What this trial is testing

Epidemiologic Multicenter Prospective Study in Advanced NSCLC (Non Small Cell Lung Cancer) Patients With PDL1 (Protein Death Ligand 1) Expression.

Who this might be right for
Lung Cancer
Groupe Francais De Pneumo-Cancerologie 170
Not applicableStudy completedNCT03413956
What this trial is testing

An Observational Study to Explore Clinical Characteristics of the Patients With T1 Non-small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
Jiangsu Cancer Institute & Hospital 10,885
Not applicableStudy completedNCT02357992
What this trial is testing

Lung Cancer STARS Trial - STARS Revised Clinical Trial Protocol: Stereotactic Ablative Radiotherapy (SABR) in Stage I Non-small Cell Lung Cancer Patients Who Can Undergo Lobectomy

Who this might be right for
Lung Cancer
M.D. Anderson Cancer Center 122
Testing effectiveness (Phase 2)Study completedNCT00103207
What this trial is testing

Cetuximab in Treating Patients With Recurrent or Stage IIIB or Stage IV Lung Cancer

Who this might be right for
Lung Cancer
Eastern Cooperative Oncology Group 72
Next Page